Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Total 13F shares
-
58,408,045
-
Share change
-
+1,703,628
-
Total reported value
-
$1,562,624,874
-
Put/Call ratio
-
27%
-
Price per share
-
$26.75
-
Number of holders
-
241
-
Value change
-
+$31,544,259
-
Number of buys
-
115
-
Number of sells
-
112
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q2 2024
As of 30 Jun 2024 SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) had 241 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 58,408,045 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, DIMENSIONAL FUND ADVISORS LP, MACQUARIE GROUP LTD, STATE STREET CORP, Polar Capital Holdings Plc, Stephens Investment Management Group LLC, RENAISSANCE TECHNOLOGIES LLC, and LOOMIS SAYLES & CO L P.
This table shows 241 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.